Investigational Site Number 643005

Nizhny Novgorod 603155

0 studies enrolling now · 2 studies all time

What they study most

Relapsing-remitting Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 — Stopped early